Moreover, previous research indicated that YXS may improve heart function in HF with the elevation of the biomarkers such as TNNI3, GAL-3, HSP 70, FABP3, and CKAP5 [6], which benefited the clinical location of YXS. The gene discussed is FABP3; the disease is hydrops fetalis.